Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:10 AM
Ignite Modification Date:
2025-12-25 @ 3:10 AM
NCT ID:
NCT00129805
Eligibility Criteria:
Inclusion Criteria:
* Cerebral infarction except cardiac source of embolism
* Onset ≧ 1 week to ≦ 6 months before randomization
* Neurological signs persisting ≧ 1 day from onset
* Computed tomography (CT) or magnetic resonance imaging (MRI) detection of responsible site
* Age ≧ 20 years
* Systolic pressure ≦ 180 mmHg; diastolic pressure ≦ 110 mmHg
Exclusion Criteria:
* Functional outcome at randomization: Modified Rankin Scale = 4, 5
* Previous or planned vascular surgery for cerebral infarction
* History of intracranial hemorrhage
* History of systemic bleeding, or other history of bleeding diathesis or coagulopathy
* Severe complications (renal or hepatic insufficiency, heart failure, hemopathy, etc.)
* Pregnant or possibly pregnant women, or nursing mothers
* History of sarpogrelate and aspirin sensitivity
* Treating malignant tumor or treated within 5 years
* Current peptic ulceration
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Study:
NCT00129805
Study Brief:
Protocol Section:
NCT00129805